Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

News | Radiopharmaceuticals and Tracers | January 06, 2017

January 6, 2017 — New research demonstrates that a novel...

MRI-guided focused ultrasound
News | Focused Ultrasound Therapy | December 22, 2016

Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...

prostate, CT scan, Dave Fornell medical
News | Prostate Cancer | December 22, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...

News | Prostate Cancer | December 14, 2016

December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on...

Exact Imaging Receives FDA 510(k) Clearance for Its ExactVu Micro-Ultrasound System
News | Prostate Cancer | December 09, 2016

Exact Imaging, a leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance...

prostate cancer, PET imaging, Johns Hopkins, Daniel Thorek, 11B6 antibody

Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek

News | Prostate Cancer | November 30, 2016

November 30, 2016 — An international group of researchers report success in mice of a method of using...

Augmenix, SpaceOAR System, prostate cancer, new CPT code, AMA, American Medical Association
Technology | Prostate Cancer | November 10, 2016

November 10, 2016 — Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I,...

News | Prostate Cancer | November 02, 2016

November 2, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests a lot more American men...

Augmenix, SpaceOAR System, prostate cancer, three-year clinical data results, ASTRO 2016
News | Prostate Cancer | October 27, 2016

October 27, 2016 — Augmenix Inc. announced the three-year results from the SpaceOAR System...

intermediate-risk prostate cancer, brachytherapy versus external beam therapy, radiation therapy, RT, ASTRO 2016
News | Brachytherapy Systems | October 25, 2016

October 25, 2016 — For men with intermediate-risk...

Axumin, fluciclovine F-18, PET agent, Phase 3 study, recurrent prostate cancer detection, Blue Earth Diagnostics
News | Prostate Cancer | October 25, 2016

October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3...

prostate cancer, SBRT, stereotactic body radiotherapy, ASTRO 2016 study, Robert Meier, control, side effects, toxicity
News | Radiation Therapy | October 06, 2016

October 6, 2016 — High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-...

prostate cancer, ProtecT trial findings, ASTRO 2016, radiation therapy
News | Radiation Therapy | October 03, 2016

September 29, 2016 — The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors...

prostate cancer, hormone therapy, cardiac risk factors, Yale Cancer Center study, ASTRO 2016
News | Cardio-oncology | September 28, 2016

September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy...

prostate cancer, hypofractionated radiationt therapy, accelerated RT, side effects, treatment time, ASTRO 2016, NRG Oncology/RTOG 0415
News | Prostate Cancer | September 27, 2016

September 27, 2016 — For men with early stage, low-risk...

prostate cancer, novel intrinsic subtypes, study, ASTRO 2016
News | Prostate Cancer | September 26, 2016

September 26, 2016 — In the largest study of its kind to date, researchers have identified and validated three...

ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy
News | Radiation Therapy | September 07, 2016

September 7, 2016 — The American Society for...

Axumin, fluciclovine F-18 injection, first injection, Northside Hospital Atlanta
News | Radiopharmaceuticals and Tracers | September 07, 2016

September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA)...